Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

United Therapeutic (UTHR)

United Therapeutic (UTHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,303,704
  • Shares Outstanding, K 44,356
  • Annual Sales, $ 2,328 M
  • Annual Income, $ 984,800 K
  • 60-Month Beta 0.57
  • Price/Sales 6.59
  • Price/Cash Flow 15.35
  • Price/Book 2.65
Trade UTHR with:

Options Overview Details

View History
  • Implied Volatility 26.95% ( -0.35%)
  • Historical Volatility 32.06%
  • IV Percentile 34%
  • IV Rank 32.09%
  • IV High 39.93% on 08/05/24
  • IV Low 20.82% on 05/09/24
  • Put/Call Vol Ratio 0.18
  • Today's Volume 26
  • Volume Avg (30-Day) 162
  • Put/Call OI Ratio 1.65
  • Today's Open Interest 8,030
  • Open Int (30-Day) 7,116

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 6.33
  • Number of Estimates 8
  • High Estimate 7.41
  • Low Estimate 5.41
  • Prior Year 5.38
  • Growth Rate Est. (year over year) +17.66%

Price Performance

See More
Period Period Low Period High Performance
1-Month
327.96 +5.82%
on 08/19/24
366.08 -5.20%
on 09/03/24
+26.05 (+8.12%)
since 08/16/24
3-Month
302.71 +14.64%
on 06/20/24
366.08 -5.20%
on 09/03/24
+41.00 (+13.40%)
since 06/18/24
52-Week
208.62 +66.35%
on 02/08/24
366.08 -5.20%
on 09/03/24
+129.56 (+59.57%)
since 09/18/23

Most Recent Stories

More News
United Therapeutics: Q2 Earnings Snapshot

United Therapeutics: Q2 Earnings Snapshot

UTHR : 345.40 (+0.11%)
Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans.

Whether you'd like to invest like Nancy Pelosi or Ted Cruz, you can. But maybe you shouldn't.

MSFT : 432.56 (-0.60%)
AAPL : 219.91 (+1.44%)
AMZN : 186.66 (-0.12%)
NVDA : 114.25 (-1.16%)
UTHR : 345.40 (+0.11%)
GOOG : 160.64 (+0.22%)
JPM : 207.87 (-0.66%)
ANET : 363.31 (+0.65%)
FIX : 361.16 (+1.19%)
NANC : 36.39 (-0.52%)
CRUZ : 22.39 (+0.62%)
Chart of the Day: United Therapeutics - Drugs for Chronic Illnesses

The Chart of the Day belongs to the pharmaceutical company United Therapeutics (UTHR) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy...

UTHR : 345.40 (+0.11%)
United Therapeutics: Q1 Earnings Snapshot

United Therapeutics: Q1 Earnings Snapshot

UTHR : 345.40 (+0.11%)
United Airlines, Dyne Therapeutics fall; Lucid Group, Century Aluminum rise, Monday, 3/25/2024

Stocks that traded heavily or had substantial price changes on Monday: United Airlines, Dyne Therapeutics fall; Lucid Group, Century Aluminum rise

CLV : 1.43 (-0.69%)
CLF : 11.58 (-1.95%)
UTHR : 345.40 (+0.11%)
CENX : 14.42 (-0.89%)
INTC : 20.91 (-2.61%)
BA : 155.56 (-0.53%)
UAL : 53.28 (+1.22%)
United Therapeutics: Q4 Earnings Snapshot

United Therapeutics: Q4 Earnings Snapshot

UTHR : 345.40 (+0.11%)
United Therapeutics: Q3 Earnings Snapshot

United Therapeutics: Q3 Earnings Snapshot

UTHR : 345.40 (+0.11%)
Markets Today: Stocks Fall as Fitch Cuts its U.S. Debt Rating

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.61%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.88%. Stock indexes this morning are lower after Fitch Ratings’...

ESZ24 : 5,708.75 (+0.15%)
NQZ24 : 19,684.00 (+0.04%)
GNRC : 143.92 (+0.14%)
PINS : 30.08 (+2.45%)
SBUX : 96.24 (-0.21%)
CCL : 18.35 (+1.77%)
EA : 140.63 (-1.37%)
CWH : 24.55 (+0.78%)
NCLH : 19.88 (+0.61%)
VFC : 19.13 (+3.97%)
CVS : 58.58 (+1.30%)
ELF : 115.18 (+2.45%)
United Therapeutics: Q2 Earnings Snapshot

United Therapeutics: Q2 Earnings Snapshot

UTHR : 345.40 (+0.11%)
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential

These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.

DNLI : 31.32 (+2.09%)
RARE : 57.97 (-0.89%)
SRPT : 125.87 (+0.14%)
PFE : 29.79 (-0.13%)
EXEL : 26.89 (-2.57%)
MRNA : 70.44 (-2.15%)
UTHR : 345.40 (+0.11%)
BIIB : 197.88 (-0.17%)
SNY : 57.22 (+0.54%)
LLY : 907.00 (+0.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

United Therapeutics Corporation markets four medicines in the United States to treat pulmonary arterial hypertension (PAH): Remodulin, an injectable formulation of treprostinil, Orenitram, an oral version of treprostinil, Tyvaso, an inhaled version of treprostinil, and Adcirca (tadalafil; also sold by...

See More

Key Turning Points

3rd Resistance Point 363.50
2nd Resistance Point 358.57
1st Resistance Point 351.79
Last Price 345.40
1st Support Level 340.08
2nd Support Level 335.15
3rd Support Level 328.37

See More

52-Week High 366.08
Last Price 345.40
Fibonacci 61.8% 305.93
Fibonacci 50% 287.35
Fibonacci 38.2% 268.77
52-Week Low 208.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar